Literature DB >> 7426339

Murine melanoma: a model for intracranial metastasis.

A Raz, I R Hart.   

Abstract

A variant subline (B16-F10-B2) selected from the B16-F10 melanoma cell line, shows greater metastatic capacity and preferential growth in the brain after i.v. injection into C57BL/6 mice. Several biological properties of these two cell lines have been compared, in an effort to determine the mechanisms responsible for this non-random metastatic pattern. No differences in cell morphology, in vitro growth rates or exposed cell-surface proteins were detected. Quantitative analysis of tumour-cell arrest and distribution using 125IUdR-labelled cells indicated that, although initial arrest patterns of the cell lines were very similar, B16-F10-B2 cells survived in the lungs to a greater cell line had a higher mean number of chromosomes than the parent line, whereas the variance of chromosome distribution was less. We suggest that the selection of a brain-colonizing variant represents the emergence of a pre-existing subpopulation of cells, and provides a useful model for studying mechanisms of intracranial metastasis.

Entities:  

Mesh:

Year:  1980        PMID: 7426339      PMCID: PMC2010379          DOI: 10.1038/bjc.1980.235

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  Editorial: Brain tumor. Current status of treatment and its complications.

Authors:  J B Posner; W R Shapiro
Journal:  Arch Neurol       Date:  1975-12

2.  Brain changes and survival of animals with tumors implanted in the brain.

Authors:  L L Gershbein; I Benuck; P S Shurrager
Journal:  Oncology       Date:  1975       Impact factor: 2.935

3.  Metastasis results from preexisting variant cells within a malignant tumor.

Authors:  I J Fidler; M L Kripke
Journal:  Science       Date:  1977-08-26       Impact factor: 47.728

4.  Diagnosis and treatment of metastases to the brain.

Authors:  J B Posner
Journal:  Clin Bull       Date:  1974

5.  Selection of successive tumour lines for metastasis.

Authors:  I J Fidler
Journal:  Nat New Biol       Date:  1973-04-04

6.  Inhibition of pulmonary metastasis by intravenous injection of specifically activated macrophages.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1974-05       Impact factor: 12.701

7.  General method for the detection of cells producing antibodies against haptens and proteins.

Authors:  P Strausbauch; A Sulica; D Givol
Journal:  Nature       Date:  1970-07-04       Impact factor: 49.962

8.  Studies on the chemotherapy of experimental brain tumors: development of an experimental model.

Authors:  J I Ausman; W R Shapiro; D P Rall
Journal:  Cancer Res       Date:  1970-09       Impact factor: 12.701

9.  Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2'-deoxyuridine.

Authors:  I J Fidler
Journal:  J Natl Cancer Inst       Date:  1970-10       Impact factor: 13.506

10.  Enzymic iodination. A probe for accessible surface proteins of normal and neoplastic lymphocytes.

Authors:  J J Marchalonis; R E Cone; V Santer
Journal:  Biochem J       Date:  1971-10       Impact factor: 3.857

View more
  22 in total

1.  Differential tumor growth of blood-borne B16 melanoma variants in cerebral dura mater is related to tumor-host cell reactions.

Authors:  T Kawaguchi; M Kawaguchi; T M Lembo; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1989 Jan-Feb       Impact factor: 5.150

2.  B16 melanoma spontaneous brain metastasis: occurrence and development within leptomeninges blood vessels.

Authors:  A L Alterman; C W Stackpole
Journal:  Clin Exp Metastasis       Date:  1989 Jan-Feb       Impact factor: 5.150

3.  Growth stimulating activity of lung extract on lung-colonizing colon 26 clones and its partial characterization.

Authors:  T Yamori; H Iida; S Tsukagoshi; T Tsuruo
Journal:  Clin Exp Metastasis       Date:  1988 Mar-Apr       Impact factor: 5.150

Review 4.  Best Practices for Preclinical In Vivo Testing of Cancer Nanomedicines.

Authors:  Danielle M Valcourt; Chintan H Kapadia; Mackenzie A Scully; Megan N Dang; Emily S Day
Journal:  Adv Healthc Mater       Date:  2020-05-04       Impact factor: 9.933

5.  B16 melanoma variants selected by one or more cycles of spontaneous metastasis to the same organ fail to exhibit organ specificity.

Authors:  C W Stackpole; A L Alterman; E F Valle
Journal:  Clin Exp Metastasis       Date:  1991 May-Jun       Impact factor: 5.150

6.  Characterization of brain and bone-metastasizing clones selected from an ethylnitrosourea-induced rat mammary carcinoma.

Authors:  D G Hall; G Stoica
Journal:  Clin Exp Metastasis       Date:  1994-07       Impact factor: 5.150

7.  Alteration of blood-brain-CSF barrier in experimental meningeal carcinomatosis. A morphologic and adriamycin-penetration study.

Authors:  T Siegal; U Sandbank; A Gabizon; T Siegal; R Mizrachi; E Ben-David; R Catane
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

8.  Brain surface invasion and metastasis of murine malignant melanoma variants.

Authors:  G L Nicolson; T Kawaguchi; M Kawaguchi; C Van Pelt
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

9.  Regional growth of different human melanomas as metastases in the brain of nude mice.

Authors:  G Schackert; J E Price; R D Zhang; C D Bucana; K Itoh; I J Fidler
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

10.  Brain meninges tumor formation by in vivo-selected metastatic B16 melanoma variants in mice.

Authors:  T Kawaguchi; M Kawaguchi; K M Miner; T M Lembo; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1983 Jul-Sep       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.